Armistice Capital, LLC Vincerx Pharma, Inc. Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 567,011 shares of VINC stock, worth $618,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
567,011
Previous 2,704,000
79.03%
Holding current value
$618,041
Previous $1.95 Million
92.14%
% of portfolio
0.0%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding VINC
# of Institutions
21Shares Held
4.8MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$1.86 Million0.1% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$971,9730.01% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$688,2220.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA286KShares$312,1450.0% of portfolio
-
Geode Capital Management, LLC Boston, MA242KShares$263,2530.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $23.1M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...